The group with the worst prognosis regarding cancer progression was also characterized by the disease advancement (metastases) and polymorphic variant in doxorubicin importer gene SLC22A16. However, in this model the picture was completed by the presence of two SNPs in progesterone receptor gene. The gene discussed is SLC22A16; the disease is cancer.